A US district court has barred privately-held orthopaedic company Arthrex from making or selling four lines of suture anchors, after ruling that the products infringed a patent licensed exclusively to Smith & Nephew by the inventor.
A US district court has barred privately-held orthopaedic company Arthrex from making or selling four lines of suture anchors, after ruling that the products infringed a patent licensed exclusively to Smith & Nephew by the inventor.
In addition, the jury in the Oregon court awarded S&N's Endoscopy subsidiary $14
Communication with patients has become a particularly crucial factor for investors, payers, and other healthcare decision-makers in a hostile market environment.
Out-of-hospital cardiac arrest remains one of the most challenging and resource-intensive emergencies in cardiovascular care. At SCAI 2025, clinicians presented a novel algorithm that improved triage decisions and reduced unnecessary interventions.
A battle may be forming over the 2027 FDA user fee reauthorizations. At a conference Friday, Democratic Rep. Jake Auchincloss supports them for their effectiveness, while Deputy FDA Commissioner Grace Graham echoed criticisms from HHS Sec. Kennedy, among others, in calling for reform to ensure public trust.
